The Department of Health has recalled a batch of Irbesartan HCT Actavis Tablets. Photo: Handout

Hong Kong health authorities issue recall of high blood pressure drug over fears batch has been infected with impurity that could cause cancer

  • Irbesartan HCT tablets, with batch number 058818, which were supplied locally by Actavis Hong Kong are subject to recall
  • Certain batches of the drug’s raw materials were found to contain N-nitrosodiethylamine (NDEA), a probable human carcinogen
Topic |   Drugs

TOP PICKS

The Department of Health has recalled a batch of Irbesartan HCT Actavis Tablets. Photo: Handout
READ FULL ARTICLE